Clinical Trials: Effects of Vitamin D Repletion in Vitamin D Deficient Patients

[okarol]

The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease

Primary Outcome Measures:
To assess the effect of vitamin D supplementation on albuminuria in CKD patients as assessed by urine albumin/creatinine measures. [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
To assess whether repletion doses of vitamin D increase 25(OH) vitamin D levels to above 30 ng/mL in a multi-ethnic sample of patients with CKD as a secondary outcome. [ Time Frame: 3 months ] [ Designated as safety issue: No ]
To assess the effect of vitamin D supplementation on mean systolic blood pressure as measured by ambulatory blood pressure in CKD patients as a secondary outcome. [ Time Frame: 3 months ] [ Designated as safety issue: No ]

more info: http://clinicaltrials.gov/ct2/show/NCT01029002?cond=%22Renal+Insufficiency%22&rank=71